Skip to main content

Table 1 Summary of studies on FAP-specific for non-malignant indications

From: Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic review

Author

Year

Non-malignant Indication (patients)

Tracer (patients)

Key findings

COI

Funding

Heckmann et al. [5]

2020

Investigation of cardiovascular disease (229 patients)

Not specified (229 patients)

High signal intensities are correlated with cardiovascular and metabolic risk factors (arterial hypertension, diabetes mellitus, obesity)

Focal enrichment patterns might be suggestive of underlying cardiovascular disease

Patent application

Fellowship of the German Center for Cardiovascular Research

Xu et al. [43]

2020

Shoulder arthritis (1 patient)

68Ga-FAPI-04 (1 patient)

FAPI-04 showed a strong uptake in the previously known arthritis

None

None

Shi et al.[44]

2020

Dilated cardiomyopathy/chronic heart failure (1 patient)

68Ga -FAPI-04 (1 patient)

FAPI-04 showed an increased, heterogeneous uptake pattern

The strongest uptake was noted in the left ventricular inferior wall

None

None

Schmidkonz et al. [6]

2020

IgG4-related disease (27 patients)

68Ga -FAPI-04 (27 patients)

FAP-specific PET can visualize fibrosis in the absence of inflammation and therefore differentiate fibrotic from inflammatory activity

Patent application

German Research Foundation, European Research Council Starting Grant, ELAN and IZKF Fonds, Wilhelm Sander Stiftung, Federal Ministry of Education and Research

Hayrapetian et al. [45]

2020

Elastofibroma dorsi (1 patient)

68Ga -FAPI-46 (1 patient)

FAPI-46 showed a moderate yet more intense uptake compared to FDG in an infrascapular elastofibroma dorsi

Equity in Sofie Biosciences

Molecular Imaging Research Grant for Junior Academic Faculty, Philippe Foundation Inc, ARC Foundation

Hao et al.[46]

2020

Tuberculosis (1 patient)

68Ga -FAPI-04 (1 patient)

FAPI-04 showed an increased uptake in tuberculous lesions in brain, lung and spine compared to FDG

None

None

Chen et al.[4]

2020

Tuberculosis (2 patients)

Pancreatitis (1 patient)

Post-treatment inflammatory reactions (2 patients)

Esogastritis (2 patients)

Hepatic adenoma (1 patient)

Pancreatic cystadenoma (1 patient)

68Ga -FAPI-04 (9 patients)

FAPI-04 showed an increased uptake in tuberculosis, pancreatitis and post treatment inflammatory reaction

No increased uptake could be found in esogastritis, hepatic adenoma and pancreatic cystadenoma

None

National Natural Science Foundation of China, key medical health projects in Xiamen

Luo et al.[47]

2020

IgG4-related disease (26 patients)

68Ga -FAPI-04 (26 patients)

FAPI-04 showed low background in the head and neck and was therefore more able to detect IgG4-related disease in this region

None

CAMS Innovation Fund for Medical Sciences

Shi et al.[48]

2020

Benign hepatic nodules with granulation tissue (1 patient)

68Ga -FAPI-04 (1 patient)

The only benign hepatic tumor in the study showed a negligible uptake

None

National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, CAMS Innovation Fund for Medical Sciences

Pang et al.[49]

2020

Possible hormonotherapy-induced chronic inflammation of the adrenals (1 patient)

Not specified (1 patient)

FAP-specific PET showed bilateral enhancement of the adrenals in a patient on total androgen blockage

None

None

Zhao et al.[50]

2020

Hepatic adenoma (1 patient)

Not specified (1 patient)

FAP-specific PET showed low enhancement in three benign hepatic nodules in a patient with liver cirrhosis

None

None

Chen et al.[51]

2020

Benign pleural nodules (1 patient)

Not specified (1 patient)

FAP-specific PET showed low enhancement in benign pleural nodules but a focally increased uptake in a lung nodule which turned out to be a primary lung adenocarcinoma

None

None

Pan et al.[52]

2020

IgG4-related disease (1 patient)

Not specified (1 patient)

While FAP-specific PET showed uptake in regions that were negative on FDG-PET such as the lacrimal glands, most FDG-avid lymph nodes were negative

None

CAMS Initiative for Innovative Medicine

Luo et al.[53]

2020

Tumor-induced pancreatitis (1 patient)

Not specified (1 patient)

FAP-specific PET showed intense uptake of an enlarged pancreas with pancreatitis masking the presence of pancreatic cancer as the underlying cause

None

CAMS Initiative for Innovative Medicine

Totzeck et al.[51]

2019

Coronary artery disease/possible cardiotoxicity (1 patient)

Not specified (1 patient)

FAP-specific PET showed intense uptake in the left ventricle in a cancer patient with a history of coronary artery disease and chemotherapy but no current acute or chronic coronary syndromes

None

None

Luo et al.[55]

2019

IgG4-related disease (1 patient)

Not specified (1 patient)

While FAP-specific PET showed uptake in regions that were negative on FDG-PET such as the pancreas, most FDG-avid lymph nodes were negative

None

CAMS Initiative for Innovative Medicine

  1. COI, conflict of interest